BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26813548)

  • 1. [Status of β-blocker use and heart rate control in Chinese patients with stable coronary artery disease].
    Sun Y; Yu J; Hu D;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jan; 44(1):19-26. PubMed ID: 26813548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate and the use of beta-blockers in stable outpatients with coronary artery disease: Polish baseline results of the CLARIFY registry.
    Stępińska J; Marona M; Greenlaw N; Steg G;
    Kardiol Pol; 2014; 72(11):1156-64. PubMed ID: 25001472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate and B-blockade in stable coronary artery disease in Greece.
    Sbarouni E; Voudris V; Georgiadou P; Hamilos M; Steg G; Fox KM; Greenlaw N; Vardas PE;
    Hellenic J Cardiol; 2015; 56(2):112-7. PubMed ID: 25854439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and clinical outcome of stable coronary artery disease in Austria : Results from 5 years of the CLARIFY registry.
    Lang IM; Badr-Eslam R; Greenlaw N; Young R; Steg PG
    Wien Klin Wochenschr; 2017 Dec; 129(23-24):879-892. PubMed ID: 28913755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate and use of β-blockers in Mexican stable outpatients with coronary artery disease.
    Alcocer-Gamba MA; Martínez-Sánchez C; Verdejo-Paris J; Ferrari R; Fox K; Greenlaw N; Steg Philippe G;
    Arch Cardiol Mex; 2015; 85(4):270-7. PubMed ID: 25921309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
    Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
    JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
    Perings S; Stöckl G; Kelm M;
    Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequate heart rate control is associated with worse quality of life in patients with coronary artery disease and chronic obstructive pulmonary disease. The RYTHMOS study.
    Andrikopoulos G; Pastromas S; Kartalis A; Toli K; Mantas I; Tzeis S; Kyrpizidis C; Olympios C; Manolis AJ; Foussas S; Kranidis A; Pras A; Pipilis A; Chryssos D; Gotsis A; Trikas A; Richter D; Alexopoulos D; Parthenakis F; Theodorakis G; Konstantinides S; Vardas P
    Hellenic J Cardiol; 2012 Mar; 53(2):118-26. PubMed ID: 22484777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient control of heart rate in stable coronary artery disease patients in Latvia.
    Balode I; Mintāle I; Latkovskis G; Jēgere S; Narbute I; Bajāre I; Greenlaw N; Steg PG; Ferrari R; Ērglis A;
    Medicina (Kaunas); 2014; 50(5):295-302. PubMed ID: 25488166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.
    Steg PG; Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox KM;
    PLoS One; 2012; 7(5):e36284. PubMed ID: 22570699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an ambulatory population with stable coronary artery disease and importance of heart rate: the PULSAR registry.
    Seabra-Gomes R;
    Rev Port Cardiol; 2010 Apr; 29(4):483-508. PubMed ID: 20734572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
    Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
    [No Abstract]   [Full Text] [Related]  

  • 16. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
    Celik O; Atasoy MM; Ertürk M; Yalçın AA; Aksu HU; Diker M; Aktürk IF; Atasoy I
    Acta Radiol; 2014 Jul; 55(6):676-81. PubMed ID: 24052362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consistency evaluation of target heart rate determined by anaerobic threshold and by resting heart rate in patients with coronary artery disease after percutaneous coronary intervention].
    Niu SP; Guo L; Guo DJ; Fan XM; Ding RJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):480-485. PubMed ID: 35589597
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy.
    Jiang J; Cong H; Zhang Y; Li Z; Tao G; Li X; Qing L; Tan N; Zhao Z; Dong Y; Ji Z; Chen Y; Ge J; He B; Sun Y; Cao K; Huo Y
    Int J Med Sci; 2017; 14(5):477-483. PubMed ID: 28539824
    [No Abstract]   [Full Text] [Related]  

  • 19. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
    Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.